|
What are some of the risk factors for asthma?
|
|
-Atopy (personal or familial)
-Maternal smoking
-Male sex if younger than 14, Female sex if older than 14
|
Show
|
|
What are the pathophysiologic features?
|
|
-Airflow obstruction
-Bronchial smooth muscle spasm
-Edema of airway mucosa
-Mucous impaction of bronchi
-Airway inflammation
-Airway hyperresponsiveness
|
Show
|
|
What are the symptoms?
|
|
-Wheezing
-Chronic day and night cough
-Shortness of breath
-Chest tightness
-Exercise intolerance
-Recurrent bronchitis or pneumonia
|
Show
|
|
What are the findings on physical exam?
|
|
-Even if patient has poorly controlled asthma the physical examination may be completely normal.
-During an acute exacerbation, physical examination may show wheezing with reduced airflow, prolonged expiratory phase, use of accessory muscles, tachypnea,
|
Show
|
|
What are the triggers of asthma?
|
|
-Allergen exposure
-Cigarette smoke
-Respiratory infections
-Strong emotion (Laughing, crying, etc.)
-Vigorous exercise
-Pets
-Air pollution
-Dust
-Household products
-Drugs (e.g. aspirin)
|
Show
|
|
How is asthma diagnosed?
|
|
In school-aged children, the diagnosis can be made by the history and pulmonary function testing. In a child with active asthma, there may be a reduction in the FEV1 and the FEV1/FVC ratio.
|
Show
|
|
How is asthma diagnosed (cont.).
|
|
In response to a bronchodilator, the FEV1/FVC ratio will improve by more than 12-15%. Normal lung function testing does not rule out asthma. Many children with symptomatic asthma will have normal pulmonary function.
|
Show
|
|
How is asthma diagnosed? (cont.)
|
|
-In children under 5, the history and the response to bronchodilator or anti-inflammatory therapy are the keys to diagnosis.
|
Show
|
|
How is asthma classified?
|
|
-Intermittent or Persistent
-Persistent is subdivided into mild, moderate and severe.
|
Show
|
|
What are some important non-pharmacological measures in the treatment of asthma?
|
|
-Trigger identification and avoidance
-Patient education about inhaler technique, monitoring disease activity, etc.
-Some patients may be advised to use peak flow meters to help monitor disease severity and provide an early warning
-Written action plan
|
Show
|
|
What is the best therapy for quick relief of symptoms?
|
|
Fast-acting beta-2 agonist. For intermittent asthma, this is the only drug therapy required.
|
Show
|
|
What is the preferred drug therapy for persistent asthma?
|
|
Inhaled corticosteroids.
|
Show
|
|
What are some adjunct therapies?
|
|
Long-acting beta-2 agonists (not to be used as monotherapy)
Leukotriene receptor antagonists
Oral systemic corticosteroids
Cromolyn
Subcutaneous allergen immunotherapy
Omalizumab
|
Show
|
|
Outline a basic approach to the management of persistent asthma.
|
|
1. General environmental control measures for all children (e.g. avoidance of environmental tobacco smoke) and specific allergen avoidance measures guided by allergy testing.
2. Patient education, written action plan and follow-up for all children
|
Show
|
|
Outline a basic approach to the management of persistent asthma. (cont.)
|
|
3. “Quick-relief” medication as needed for all children (but excessive use indicates poorly controlled asthma)
4. “Controller” medications in a stepwise fashion depending on severity:
|
Show
|
|
Outline a basic approach to the management of persistent asthma. (cont.)
|
|
a. Start with low-dose inhaled corticosteroids, increasing dose if needed to achieve and maintain control. May also start with a moderate-high dose inhaled corticosteroids until well-controlled and then weaning to lowest dose that maintains good control
|
Show
|
|
Outline a basic approach to the management of persistent asthma. (cont.)
|
|
b. Consider add-on therapies with increasing severity
c. Consider oral corticosteroids in severe cases
5. Regularly assess control, triggers, compliance, inhaler technique and co-morbidity
|
Show
|
|
What is the prognosis?
|
|
-Generally excellent. Many children with mild symptoms “outgrow” their asthma.
-Deaths tend to result from under-recognition of symptom severity or from undertreatment.
|
Show
|